Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression of T-plastin, FoxP3 and other tumor-associated markers by leukemic T-cells of cutaneous T-cell lymphoma

1 Jan 2008

Abstract excerpt

Peripheral blood cells from 28 patients with leukemic cutaneous T-cell lymphoma including 25 patients with Sezary syndrome were evaluated for expression of regulatory T-cell-associated markers (FoxP3, CD25, CTLA-4, neurophilin-1), T-cell activation markers (CD28 and its ligands B7.1 and B7.2) and NK cell-associated markers (NKG2D and its ligands Mic-A and Mic-B) using real-time quantitative polymerase chain...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cutaneous lymphoproliferative disorders research
Share to Immune Cell Function and Interaction
Share to T-cell and Retrovirus Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 18569641
DOI: 10.1080/10428190802064917

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression of T-plastin, FoxP3 and other tumor-associated markers by leukemic T-cells of cutaneous T-cell lymphomaPMID 18569641Read ↗

Sézary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3Semantic proximity Read ↗

Sézary syndrome: old enigmas, new targets.Semantic proximity Read ↗

Regulation of T-plastin expression by promoter hypomethylation in primary cutaneous T-cell lymphoma.Semantic proximity Read ↗

Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype.Semantic proximity Read ↗

CD158k and PD-1 expressions define heterogeneous subtypes of Sezary syndromeSemantic proximity Read ↗

Dysregulation of the TOX-RUNX3 pathway in cutaneous T-cell lymphomaSemantic proximity Read ↗

FOXP3+CD25- tumor cells with regulatory function in Sézary syndrome.Semantic proximity Read ↗

Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation.Semantic proximity Read ↗

Th1 Response and Cytotoxicity Genes Are Down-Regulated in Cutaneous T-Cell LymphomaSemantic proximity Read ↗

MicroRNA expression in Sézary syndrome: identification, function, and diagnostic potentialSemantic proximity Read ↗

T-cell receptor-γ in gamma-delta phenotype cutaneous T-cell lymphoma can be accompanied by atypical expression of CD30, CD4, or TCRβF1 and an indolent clinical course.Semantic proximity Read ↗

Malignant Tregs express low molecular splice forms of FOXP3 in Sézary syndromeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.